Immunotherapy Combined with Metronomic Dosing: An Effective Approach for the Treatment of NSCLC

Immunotherapy Combined with Metronomic Dosing: An Effective Approach for the Treatment of NSCLC

Pioneering studies on tumor and immune cell interactions have highlighted immune checkpoint inhibitors (ICIs) as revolutionizing interventions for the management of NSCLC, typically combined with traditional MTD chemotherapies, which usually lead to toxicities and resistance to treatment. Alternativ...

Full description

Bibliographic Details
Main Authors: Eleni Skavatsou, Maria Semitekolou, Ioannis Morianos, Theodoros Karampelas, Nikolaos Lougiakis, Georgina Xanthou, Constantin Tamvakopoulos
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
non-small cell lung cancer
metronomic chemotherapy
gemcitabine
oral agents
immunotherapy
efficacy
Online Access:https://www.mdpi.com/2072-6694/13/8/1901

Internet

https://www.mdpi.com/2072-6694/13/8/1901

Similar Items